Thursday, December 13, 2018

Sponsors

  • ORGANIZED BY

Health Daily is a daily, electronic newsletter, providing its subscribers with reliable and comprehensive information on health and pharma industry in Greece. It includes news for political and financial decisions and evolutions of health, such as healthcare reforms, strategic alliances between pharmaceutical companies, international news etc. In this context, Health Daily organizes a variety of specific conferences for Healthcare Sector such as “The Future of Healthcare in Greece” and the «Patients in Power” Conference.

  • IN COOPERATION WITH

The Pan-Hellenic Union of Pharmaceutical Industry (PEF) represents a total of 40 domestic pharmaceutical manufacturers in Greece. Altogether its members export to more than 85 countries worldwide and conduct over 80 research programs in collaboration with the academia. PEF maintains a workforce of over 11.000 employees, of which 900 are highly skilled researchers and the industry’s annual contribution to the national GDP is estimated at €2.8 billion. PEF's members develop and produce mainly branded generics in more than 27 production units and address all key therapeutic areas in absolute compliance with both EMA and GMP guidelines and quality standards.

SFEE, The Hellenic Association of Pharmaceutical Companies is one of the most innovative, productive and extravert branches of national economy. It represents more than 90% of the pharmaceutical companies active in our country. The 65 member-companies (24 Hellenic and 41 multinational companies), constantly invest in the development of effective medicines and treatments, in order to secure every citizen’s right to health and to a better standard of living.
PIF (Pharma Innovation Forum)
PIF (Pharma Innovation Forum)

PhRMA Innovation Forum represents the biggest pharmaceutical companies in the field of research and biotechnology which support innovation, development and access for Greek patients to safe and effective medicines, creating value for both the Greek economy and society. Members of PIF are:
ABBVIE , AMGEN HELLAS, ASTRAZENECA HELLAS, BAYER HELLAS , BMS HELLAS , CSL BEHRING HELLAS, GENESIS PHARMA, GILEAD SCIENCES, GSK, JANSSEN- CILAG, MERCKSERONO HELLAS, MSD , NOVARTIS HELLAS, NOVO NORDISK HELLAS, PFIZER HELLAS, PHARMASERVE- LILLY , ROCHE HELLAS , SANOFI-AVENTIS, SHIRE HELLAS, UCB

  • GRAND SPONSOR

Headquartered in Chicago (U.S.), GE Healthcare is a $18 billion unit of General Electric Company that provides transformational medical technologies and services for patient care. Worldwide, GE Healthcare employs more than 50,000 people committed to serving healthcare professionals and their patients in more than 100 countries. Within the European Union, we work with healthcare leaders and policy makers to support the policy changes necessary to secure a shift to sustainable, high quality healthcare systems in line with our “Healthymagination” vision - to reduce cost, increase access and improve the quality of healthcare.

Primary Business Areas:
Imaging: A global technology leader developing solutions based on a broad portfolio (MR, CT, PET, Nuclear Medicine, X-Ray, Women’s Health, Interventional and Surgery products, imaging analytics and software).
Clinical Care Solutions: Provides customers with a variety of medical solutions (ultrasound, monitoring technology, maternal infant care, anesthesia, respiratory care and cardiology).
Life Sciences: Provides expertise, tools and solutions for a wide range of applications on molecular and precision medicine (basic research of cells and proteins, drug discovery, cell therapy and regenerative medicine). GE Healthcare provides the tools, insight and knowledge to guide customers from better biological understanding to better clinical therapies.
Partners: GE’s healthcare management consultancy helps providers imagine and achieve their strategic objectives. Practice areas include strategy, culture change, care management, clinical transformation and advanced analytics. “Partners” is dedicated to improving healthcare for the benefit of patients and the providers who serve them.

  • SPONSORS

At Janssen, the pharmaceutical companies of Johnson & Johnson, we are actively developing treatments for our patients in five important therapeutic areas of healthcare (Oncology, Neuroscience, Immunology, Infectious diseases & vaccines, Cardiovascular & Metabolic diseases). We are focused on operating in transparency and on building trust. We work for change that will improve access to medicines: the best available treatment at an affordable price. We are looking at a future where patients and their families have a new sense of hope. Hope for a cure.
For more information, please visit us at http://www.janssen.com/greece/.

About Pfizer Inc.: Working together for a healthier world®
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.
To learn more, please visit us at www.pfizer.gr

The Organization "Thalpos-Mental Health" is a non-profit and non-governmental organization established in 2005 with an active role in the intervention and the information on mental health and in managing social care programs. The cornerstone of the Organization was the establishment, the organization and the operation of the two Psychosocial Rehabilitation Units (PRU) for people with chronic mental disorders, “Thalpos Attica” and “Thalpos Kalamata". The Units operate in accordance with the Greek Mental Health Reform Framework and the Program “Psychargos" under the supervision of the Ministry of Health. Since 2007 the Organization has worked with local, national and European bodies for the development and the implementation of action plans on entrepreneurship, employment, social integration, mental health and welfare.

  • SUPPORTERS

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 55,000 employees worldwide.
Learn more at iqvia.com.

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions.

At Siemens Healthineers, we want to make healthcare providers succeed in an ever-changing healthcare industry, by helping them deliver better outcomes at lower costs. Being a leading global healthcare company, with more than 46.000 employees, Siemens Healthineers is continuously developing its portfolio, from medical imaging and laboratory diagnostics, to adding managed services, consulting, and healthcare IT services – as well as further technologies for therapeutic and molecular diagnostics.

  • EXHIBITOR
  • MEDIA PARTNER
  • MEDIA SPONSORS
  • CONFERENCE EXPERIENCE SPONSOR

Conferience is an interactive web-app facilitating direct interactive possibilities among speakers and audiences for events such as: lectures, presentations, conferences, polling, training courses, seminars, focus groups, research & (executive) meetings.

Become a sponsor

To find out more about your sponsorship benefits contact with with:

Chrisoula Kordouli, tel.: +30 210 661 77 77 (ext. 278), fax: +30 210 661 77 78, e-mail: ckordouli@boussias.com

  • ORGANIZED BY
  • IN COOPERATION WITH
PIF (Pharma Innovation Forum)
PIF (Pharma Innovation Forum)
  • GRAND SPONSOR
  • SPONSORS
  • SUPPORTERS
  • EXHIBITOR
  • MEDIA PARTNER
  • MEDIA SPONSORS
  • CONFERENCE EXPERIENCE SPONSOR

© 2018 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team